{
    "2018-10-22": [
        [
            {
                "time": "",
                "original_text": "长春高新：董秘今日增持3800股，增持均价183.25元/股",
                "features": {
                    "keywords": [
                        "长春高新",
                        "董秘",
                        "增持",
                        "3800股",
                        "183.25元/股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "长春高新:核心制药业务稳定增长",
                "features": {
                    "keywords": [
                        "长春高新",
                        "核心制药",
                        "稳定增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "光大证券：长春高新买入评级",
                "features": {
                    "keywords": [
                        "光大证券",
                        "长春高新",
                        "买入评级"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【财通医药】长春高新(000661)：业绩符合预期，中长期增长确定性强",
                "features": {
                    "keywords": [
                        "财通医药",
                        "长春高新",
                        "业绩",
                        "中长期增长",
                        "确定性强"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "长春高新(000661)点评",
                "features": {
                    "keywords": [
                        "长春高新",
                        "点评"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "【医药-崔文亮】长春高新三季报点评：业绩继续高增长，生长激素处于放量增长周期",
                "features": {
                    "keywords": [
                        "医药",
                        "崔文亮",
                        "长春高新",
                        "三季报",
                        "高增长",
                        "生长激素",
                        "放量增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "首批上市公司三季报显示社保基金新进8只个股",
                "features": {
                    "keywords": [
                        "上市公司",
                        "三季报",
                        "社保基金",
                        "新进",
                        "个股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报:政策底部明显,绩优股或反弹",
                "features": {
                    "keywords": [
                        "医药行业",
                        "周报",
                        "政策底部",
                        "绩优股",
                        "反弹"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "长春高新:医药营收快速增长,公司业绩略超预期",
                "features": {
                    "keywords": [
                        "长春高新",
                        "医药营收",
                        "快速增长",
                        "业绩",
                        "略超预期"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}